Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring2020Vol. 12(1), pp. e12104–e12104
Citations Over TimeTop 10% of 2020 papers
Xue‐Ning Shen, Jieqiong Li, Hui‐Fu Wang, Hong‐Qi Li, Yuyuan Huang, Yuxiang Yang, Lan Tan, Qiang Dong, Jin‐Tai Yu, Alzheimer's Disease Neuroimaging Initiative
Abstract
Plasma A/T/N biomarker profiles may predict AD pathology and clinical progression, indicating a potential role for plasma biomarkers in clinical trials. More research is warranted to develop a robust plasma AD framework.
Related Papers
- Advances in neurology. Behavioral neurology of movement disorders.(1996)
- → Fellowship Programs in Behavioral Neurology(1995)2 cited
- → Dementia and behavioral neurology: recent advances(2012)1 cited
- → Issues in Behavioral Neurology and Brain Injury(1989)3 cited
- → Book ReviewPrinciples of Behavioral Neurology Tests of Directed Attention and Memory for Principles of Behavioral Neurology(1986)